Search over 3,000 reports

    Tafinlar- Drug Insight, 2017

    Tafinlar- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0021
    "Tafinlar - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Tafinlar. It includes Tafinlar`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Tafinlar`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Tafinlar till 2020. The report also throws light on Tafinlar`s market competition and emerging therapies in the same space as Tafinlar. A SWOT analysis of Tafinlar is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Tafinlar in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Tafinlar in United States, Europe, China and India
    • The report contains historical and forecasted sales for Tafinlar till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Tafinlar operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Tafinlar

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Tafinlar
    • Access to Tafinlar`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Tafinlar`s patents for the major markets- US and EU
    • Understand Tafinlar`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Tafinlar
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Tafinlar
    • Identify opportunities in the same area as Tafinlar with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Tafinlar - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Tafinlar Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Tafinlar, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Tafinlar Product Details, United States
    Table 8: Tafinlar Product Details, Europe
    Table 9: Tafinlar, Historical Global Sales till 2017 (in million USD)
    Table 10: Tafinlar, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Tafinlar
    Table 12: Tafinlar Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Tafinlar
    Figure 2: Tafinlar, Historical Global Sales till 2017 (in million USD)
    Figure 3: Tafinlar, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Tafinlar
    Figure 5: API Manufacturers Region wise

    Tafinlar Marketed Drugs Overview

    Tafinlar Market Assessment

    Tafinlar API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Tafinlar US DMF

    Tafinlar US Drug Master Files

    Tafinlar Active Substance Master File/ EUDMF

    Tafinlar Generic players

    Tafinlar Patent Expiration

    Tafinlar Patent Exclusivity

    Tafinlar API Manufacturers

    Tafinlar Global Forecasted Sales Figure

    Tafinlar API Route of Synthesis

    Tafinlar Market sales

    Tafinlar SWOT Analysis

    Tafinlar Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap